Humana Stock Price, News & Analysis

Humana Inc. (NYSE: HUM) has announced that its Kentucky HMO plan has received a 5-star quality rating from the Centers for Medicare and Medicaid Services (CMS) for the 2023 plan year, marking the second consecutive year of this achievement. This rating reflects Humana's commitment to high-quality care and patient-centered outcomes. Humana aims to provide financial savings to Medicare Advantage members, who reported nearly $2,000 less in out-of-pocket costs compared to traditional Medicare. The Medicare Advantage Annual Election Period begins on Oct. 15.

Humana Inc (NYSE: HUM) has announced its statewide HMO Medicare Advantage plan in Tennessee has received a 5-star rating from the Centers for Medicare & Medicaid Services (CMS) for the second consecutive year, marking the third time overall. This achievement underscores Humana's commitment to high-quality healthcare and member satisfaction. The rating reflects positive patient experiences and effective healthcare delivery, with Medicare Advantage members reportedly saving nearly $2,000 on out-of-pocket costs compared to traditional Medicare.

Humana Inc. (NYSE: HUM) has announced that its Louisiana Medicare Advantage HMO plan received a 5-star rating from the Centers for Medicare and Medicaid Services (CMS) for the second consecutive year. With nearly 196,000 members, this plan exemplifies Humana's commitment to high-quality care and patient outcomes. Region President Matt Berger highlighted the importance of tailored health plans, emphasizing increased member engagement in health management and expanded service to rural communities. The company aims to improve health and financial savings for Medicare beneficiaries.

Humana Inc. (NYSE: HUM) announced its Medicare Star Ratings, receiving a perfect 5-star rating for HMO plans in Louisiana, Tennessee, and Kentucky, encompassing around 356,000 members. Additionally, it achieved a 4.5-star rating for its Medicare Advantage plans in 46 states and Puerto Rico, servicing over 3 million members—almost double from the previous year. Notably, 96% of Humana's Medicare Advantage members are in plans rated 4 stars or above for 2023. The company emphasizes its commitment to high-quality care and customer satisfaction, reflecting well in these ratings.

Humana Inc. (NYSE: HUM) will announce its financial results for the third quarter of 2022 on November 2, 2022, at 6:30 a.m. Eastern time. A conference call to discuss the results and earnings guidance for 2022 will follow at 9:00 a.m. Eastern time. Participants can join via telephone after registering through a provided link. The earnings report will likely include non-GAAP financial measures, reconciled to GAAP metrics. The earnings news release will be available on Humana’s Investor Relations page.

Humana Inc. (NYSE: HUM) has announced its 2023 Medicare Advantage and Prescription Drug Plan offerings, emphasizing member feedback. The initiative follows a commitment to $1 billion in cost savings for program enhancements. Humana offers more $0 premium plans, expanded coverage in 260 new counties, and enhanced benefits like dental care and simplified prescription access. The company aims to improve affordability and accessibility for Medicare beneficiaries.

Humana Inc. (NYSE: HUM) has committed $1 million to aid recovery efforts for Hurricane Ian in Florida and Hurricane Fiona in Puerto Rico. The funding will support immediate relief, focusing on basic needs like food, water, and medical care. Additionally, Humana established a crisis hotline offering free counseling services. To further support employees, the Humana Foundation will match employee donations up to $500. These actions showcase Humana's commitment to community support and health equity in the wake of these devastating storms.

Humana Inc. (NYSE: HUM) has received high rankings in the 2022 Hispanic Association on Corporate Responsibility (HACR) Corporate Inclusion Index. The company scored 5 out of 5 stars in Employment, Procurement, and Philanthropy, and 4 out of 5 stars in Governance. This recognition reflects Humana's commitment to supporting Hispanic and Latinx inclusion in various corporate spheres. The insights gained will guide Humana's strategic initiatives in diversity and belonging, aiming to foster an inclusive workplace culture.

Humana Inc. (NYSE: HUM) announced a mid-term Adjusted EPS target of $37.00 for FY 2025, indicating a 14% annual growth from the updated FY 2022 outlook. The company raised its FY 2022 GAAP EPS guidance to approximately $23.08 and Adjusted EPS to approximately $25.00, reflecting a 21% increase from FY 2021. This growth is attributed to favorable medical cost trends in Medicare Advantage and the absence of expected COVID-19 disruptions. Humana continues to emphasize operational efficiencies and capital deployment for sustained earnings growth.